CRESCENT BIOPHARMA, INC. Increase (Decrease) in Accrued Liabilities
CRESCENT BIOPHARMA, INC. (CBIO) reported Increase (Decrease) in Accrued Liabilities of -$2.87 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2025-05-14
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was -$2.87M.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was $1.90M.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $521.15K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was -$951.06K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $156.19K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$1.77M.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$1.72M.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accrued liabilities for fiscal 2021 was -$988.84K, a 199.54% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accrued Liabilities 130 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$2.87M 10-Q · filed 2025-05-14 | -$965.67K derived: sum of 2 quarters · filed 2025-05-14 | -$444.52K derived: sum of 3 quarters · filed 2025-05-14 | -$1.40M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.42M derived: sum of 2 quarters · filed 2025-02-13 | $1.47M derived: sum of 3 quarters · filed 2025-02-13 | $156.19K 10-K · filed 2025-02-13 | |||||
| 2024-09-30 | $521.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$429.91K derived: sum of 2 quarters · filed 2024-11-13 | -$1.75M 10-Q · filed 2024-11-13 | -$1.83M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2024-06-30 | -$951.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.27M 10-Q · filed 2024-08-08 | -$2.35M derived: sum of 3 quarters · filed 2025-05-14 | -$2.55M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2024-03-31 | -$1.32M 10-Q · filed 2025-05-14 | -$1.40M derived: sum of 2 quarters · filed 2025-05-14 | -$1.60M derived: sum of 3 quarters · filed 2025-05-14 | -$1.70M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | -$85.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$284.71K derived: sum of 2 quarters · filed 2025-02-13 | -$382.77K derived: sum of 3 quarters · filed 2025-02-13 | -$1.77M 10-K · filed 2025-02-13 | |||||
| 2023-09-30 | -$198.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$296.95K derived: sum of 2 quarters · filed 2024-11-13 | -$1.68M 10-Q · filed 2024-11-13 | -$500.26K derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | -$98.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.48M 10-Q · filed 2024-08-08 | -$301.36K derived: sum of 3 quarters · filed 2024-08-08 | -$1.10M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | -$1.38M 10-Q · filed 2024-05-09 | -$203.31K derived: sum of 2 quarters · filed 2024-05-09 | -$1.00M derived: sum of 3 quarters · filed 2024-05-09 | -$3.87M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $381.34K derived: sum of 2 quarters · filed 2024-03-27 | -$2.49M derived: sum of 3 quarters · filed 2024-03-27 | -$1.72M 10-K · filed 2024-03-27 | |||||
| 2022-09-30 | -$799.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$3.67M derived: sum of 2 quarters · filed 2023-11-03 | -$2.90M 10-Q · filed 2023-11-03 | -$2.02M derived: sum of 4 quarters · filed 2024-03-27 | |||||
| 2022-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$2.10M 10-Q · filed 2023-08-02 | -$1.22M derived: sum of 3 quarters · filed 2024-03-27 | -$1.92M derived: sum of 4 quarters · filed 2024-03-27 | |||||
| 2022-03-31 | $761.66K 10-Q · filed 2023-05-03 | $1.64M derived: sum of 2 quarters · filed 2024-03-27 | $943.16K derived: sum of 3 quarters · filed 2024-03-27 | $1.33M derived: sum of 4 quarters · filed 2024-03-27 | |||||
| 2021-12-31 | $881.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $181.50K derived: sum of 2 quarters · filed 2024-03-27 | $563.54K derived: sum of 3 quarters · filed 2024-03-27 | -$988.84K 10-K · filed 2024-03-27 | |||||
| 2021-09-30 | -$700.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$318.08K derived: sum of 2 quarters · filed 2022-11-09 | -$1.87M 10-Q · filed 2022-11-09 | -$2.14M 10-Q · filed 2021-11-02 | -$26.15K derived: sum of 4 quarters · filed 2023-03-29 | ||||
| 2021-06-30 | $382.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.17M 10-Q · filed 2022-08-03 | -$1.31M 10-Q · filed 2021-08-05 | $673.97K derived: sum of 3 quarters · filed 2023-03-29 | $1.05M derived: sum of 4 quarters · filed 2023-03-29 | ||||
| 2021-03-31 | -$1.55M 10-Q · filed 2022-04-28 | -$1.66M 10-Q · filed 2021-05-03 | $291.93K derived: sum of 2 quarters · filed 2023-03-29 | $672.04K derived: sum of 3 quarters · filed 2023-03-29 | $1.50M derived: sum of 4 quarters · filed 2023-03-29 | ||||
| 2020-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $2.22M derived: sum of 2 quarters · filed 2023-03-29 | $3.05M derived: sum of 3 quarters · filed 2023-03-29 | $993.42K 10-K · filed 2023-03-29 | $729.09K 10-K · filed 2021-03-02 | ||||
| 2020-09-30 | $380.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.21M derived: sum of 2 quarters · filed 2021-11-02 | -$850.89K 10-Q · filed 2021-11-02 | -$384.97K derived: sum of 4 quarters · filed 2022-03-03 | |||||
| 2020-06-30 | $828.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$1.23M 10-Q · filed 2021-08-05 | -$765.07K derived: sum of 3 quarters · filed 2022-03-03 | $634.96K derived: sum of 4 quarters · filed 2022-03-03 | |||||
| 2020-03-31 | -$2.06M 10-Q · filed 2021-05-03 | -$1.59M derived: sum of 2 quarters · filed 2022-03-03 | -$193.72K derived: sum of 3 quarters · filed 2022-03-03 | $951.13K derived: sum of 4 quarters · filed 2022-03-03 | |||||
| 2019-12-31 | $465.92K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.87M derived: sum of 2 quarters · filed 2022-03-03 | $3.01M derived: sum of 3 quarters · filed 2022-03-03 | $2.71M 10-K · filed 2022-03-03 | |||||
| 2019-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $2.54M derived: sum of 2 quarters · filed 2020-11-06 | $2.24M 10-Q · filed 2020-11-06 | $2.56M derived: sum of 4 quarters · filed 2021-03-02 | |||||
| 2019-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $844.03K 10-Q · filed 2020-07-31 | $1.16M derived: sum of 3 quarters · filed 2021-03-02 | $3.13M derived: sum of 4 quarters · filed 2021-03-02 | |||||
| 2019-03-31 | -$300.82K 10-Q · filed 2020-05-01 | $17.80K derived: sum of 2 quarters · filed 2021-03-02 | $1.99M derived: sum of 3 quarters · filed 2021-03-02 | $1.14M derived: sum of 4 quarters · filed 2021-03-02 | |||||
| 2018-12-31 | $318.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $2.29M derived: sum of 2 quarters · filed 2021-03-02 | $1.44M derived: sum of 3 quarters · filed 2021-03-02 | $551.15K 10-K · filed 2021-03-02 | |||||
| 2018-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.12M derived: sum of 2 quarters · filed 2019-11-07 | $232.53K 10-Q · filed 2019-11-07 | $832.08K derived: sum of 4 quarters · filed 2020-02-28 | |||||
| 2018-06-30 | -$850.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$1.74M 10-Q · filed 2019-08-01 | -$1.14M derived: sum of 3 quarters · filed 2020-02-28 | -$981.98K derived: sum of 4 quarters · filed 2020-02-28 | |||||
| 2018-03-31 | -$887.74K 10-Q · filed 2019-05-02 | -$288.19K derived: sum of 2 quarters · filed 2020-02-28 | -$131.27K derived: sum of 3 quarters · filed 2020-02-28 | $585.46K derived: sum of 4 quarters · filed 2020-02-28 | |||||
| 2017-12-31 | $599.55K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $756.47K derived: sum of 2 quarters · filed 2020-02-28 | $1.47M derived: sum of 3 quarters · filed 2020-02-28 | $724.80K 10-K · filed 2020-02-28 | |||||
| 2017-09-30 | $156.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $873.65K derived: sum of 2 quarters · filed 2018-11-02 | $125.25K 10-Q · filed 2018-11-02 | $743.33K derived: sum of 4 quarters · filed 2019-03-06 | |||||
| 2017-06-30 | $716.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$31.67K 10-Q · filed 2018-08-09 | $586.41K derived: sum of 3 quarters · filed 2019-03-06 | $130.04K derived: sum of 4 quarters · filed 2019-03-06 | |||||
| 2017-03-31 | -$748.40K 10-Q · filed 2018-05-03 | -$130.32K derived: sum of 2 quarters · filed 2019-03-06 | -$586.69K derived: sum of 3 quarters · filed 2019-03-06 | -$30.99K derived: sum of 4 quarters · filed 2019-03-06 | |||||
| 2016-12-31 | $618.08K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $161.72K derived: sum of 2 quarters · filed 2019-03-06 | $717.41K derived: sum of 3 quarters · filed 2019-03-06 | -$2.50M 10-K · filed 2019-03-06 | |||||
| 2016-09-30 | -$456.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $99.33K derived: sum of 2 quarters · filed 2017-11-08 | -$3.12M 10-Q · filed 2017-11-08 | -$2.16M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2016-06-30 | $555.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$2.67M 10-Q · filed 2017-08-03 | -$1.70M derived: sum of 3 quarters · filed 2018-03-06 | -$1.13M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2016-03-31 | -$3.22M 10-Q · filed 2017-05-08 | -$2.26M derived: sum of 2 quarters · filed 2018-03-06 | -$1.69M derived: sum of 3 quarters · filed 2018-03-06 | $1.11M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2015-12-31 | $965.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $1.53M derived: sum of 2 quarters · filed 2018-03-06 | $4.33M derived: sum of 3 quarters · filed 2018-03-06 | $1.69M 10-K · filed 2018-03-06 | |||||
| 2015-09-30 | $565.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $3.36M derived: sum of 2 quarters · filed 2016-11-04 | $727.70K 10-Q · filed 2016-11-04 | $2.20M derived: sum of 4 quarters · filed 2017-03-01 | |||||
| 2015-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $161.79K 10-Q · filed 2016-08-04 | $1.64M derived: sum of 3 quarters · filed 2017-03-01 | $2.64M derived: sum of 4 quarters · filed 2017-03-01 | |||||
| 2015-03-31 | -$2.64M 10-Q · filed 2016-05-04 | -$1.16M derived: sum of 2 quarters · filed 2017-03-01 | -$161.13K derived: sum of 3 quarters · filed 2017-03-01 | $2.11M derived: sum of 4 quarters · filed 2017-03-01 | |||||
| 2014-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.48M derived: sum of 2 quarters · filed 2017-03-01 | $4.75M derived: sum of 3 quarters · filed 2017-03-01 | $4.46M 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $3.28M derived: sum of 2 quarters · filed 2015-11-12 | $2.98M 10-Q · filed 2015-11-12 | $3.03M derived: sum of 4 quarters · filed 2016-02-29 | |||||
| 2014-06-30 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.98M 10-Q · filed 2015-08-06 | $2.02M derived: sum of 3 quarters · filed 2016-02-29 | $2.11M derived: sum of 4 quarters · filed 2016-02-29 | |||||
| 2014-03-31 | -$292.76K 10-Q · filed 2015-05-05 | -$252.17K derived: sum of 2 quarters · filed 2016-02-29 | -$161.94K derived: sum of 3 quarters · filed 2016-02-29 | $276.01K derived: sum of 4 quarters · filed 2016-02-29 | $1.52M 10-Q · filed 2014-05-09 | ||||
| 2013-12-31 | $40.59K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $130.81K derived: sum of 2 quarters · filed 2016-02-29 | $568.77K derived: sum of 3 quarters · filed 2016-02-29 | $187.13K 10-K · filed 2016-02-29 | |||||
| 2013-09-30 | $90.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $528.19K derived: sum of 2 quarters · filed 2014-10-31 | $146.55K 10-Q · filed 2014-10-31 | ||||||
| 2013-06-30 | $437.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $56.32K 10-Q · filed 2014-07-31 | |||||||
| 2013-03-31 | -$381.64K 10-Q · filed 2014-05-09 | ||||||||
| 2012-12-31 | $16.48K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |